XML 38 R22.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 29, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Stock-Based Compensation | Note 14 – Stock-Based Compensation The Company sponsors a shareholder-approved 10-year stock incentive plan covering 2,500,000 shares of SpartanNash’s common stock. The SpartanNash Company Stock Incentive Plan of 2015 (the “2015 Plan”) provides for the granting of stock options, stock appreciation rights, restricted stock, restricted stock units, stock awards, and other stock-based and stock-related awards to directors, officers and other key associates. Shares issued, as a result of stock option exercises, will be funded with the issuance of new shares. Holders of restricted stock and stock awards are entitled to participate in cash dividends and dividend equivalents. As of December 29, 2018, a total of 1,475,633 shares remained unissued under the 2015 Plan. All outstanding unvested stock options and unvested shares of restricted stock vest immediately upon a “Change in Control,” as defined by the Plan. The Company has not issued any stock options since 2009 and all outstanding options are vested. The following table summarizes stock option activity for 2018, 2017 and 2016:
|  |  |  |  |  |  |  |  |  |  | Weighted |  |  |  |  |  |
|  |  |  |  |  | Weighted |  |  | Average |  |  |  |  |  |
|  |  |  |  |  | Average |  |  | Remaining |  |  | Aggregate |
| Shares |  |  | Exercise |  |  | Contractual |  |  | Intrinsic Value |
| Under Options |  |  | Price |  |  | Life Years |  |  | (in thousands) |
Options outstanding and exercisable at January 2, 2016 |  |  | 308,793 |  |  | $ |  | 21.15 |  |  |  |  | 2.46 |  |  | $ |  | 773 |
Exercised |  |  | (107,338 | ) |  |  |  | 23.46 |  |  |  |  |  |  |  |  |  | 1,043 |
Cancelled/Expired |  |  | (938 | ) |  |  |  | 14.36 |  |  |  |  |  |  |  |  |  |  |
Options outstanding and exercisable at December 31, 2016 |  |  | 200,517 |  |  |  |  | 19.94 |  |  |  |  | 1.65 |  |  |  |  | 3,929 |
Exercised |  |  | (152,589 | ) |  |  |  | 21.02 |  |  |  |  |  |  |  |  |  | 1,832 |
Cancelled/Expired |  |  | — |  |  |  |  | — |  |  |  |  |  |  |  |  |  |  |
Options outstanding and exercisable at December 30, 2017 |  |  | 47,928 |  |  |  |  | 16.52 |  |  |  |  | 1.07 |  |  |  |  | 487 |
Exercised |  |  | (20,476 | ) |  |  |  | 13.87 |  |  |  |  |  |  |  |  |  |  |
Cancelled/Expired |  |  | (14,400 | ) |  |  |  | 22.69 |  |  |  |  |  |  |  |  |  |  |
Options outstanding and exercisable at December 29, 2018 |  |  | 13,052 |  |  | $ |  | 13.87 |  |  |  |  | 0.37 |  |  | $ |  | 39 |
Cash received from option exercises was $0.3 million, $3.2 million and $2.5 million in 2018, 2017 and 2016, respectively. Restricted shares awarded to associates vest ratably over a four-year service period and over one year for grants to the Board of Directors. Awards are subject to forfeiture and certain transfer restrictions prior to vesting. Compensation expense, representing the fair value of the stock at the measurement date of the award, is recognized over the required service period. The following table summarizes restricted stock activity for 2018, 2017 and 2016:
|  |  |  |  |  |  |  |  |  |  |  | Weighted Average |
|  |  |  |  |  |  |  |  |  |  |  | Grant-Date |
|  |  |  |  |  |  | Shares |  |  | Fair Value |
Outstanding and nonvested at January 2, 2016 |  |  |  |  |  |  |  |  | 637,555 |  |  | $ |  | 24.75 |
Granted |  |  |  |  |  |  |  |  | 314,944 |  |  |  |  | 28.34 |
Vested |  |  |  |  |  |  |  |  | (255,156 | ) |  |  |  | 24.56 |
Forfeited |  |  |  |  |  |  |  |  | (37,200 | ) |  |  |  | 25.80 |
Outstanding and nonvested at December 31, 2016 |  |  |  |  |  |  |  |  | 660,143 |  |  |  |  | 26.48 |
Granted |  |  |  |  |  |  |  |  | 296,297 |  |  |  |  | 34.68 |
Vested |  |  |  |  |  |  |  |  | (258,183 | ) |  |  |  | 25.90 |
Forfeited |  |  |  |  |  |  |  |  | (84,513 | ) |  |  |  | 29.11 |
Outstanding and nonvested at December 30, 2017 |  |  |  |  |  |  |  |  | 613,744 |  |  |  |  | 30.32 |
Granted |  |  |  |  |  |  |  |  | 482,572 |  |  |  |  | 17.00 |
Vested |  |  |  |  |  |  |  |  | (260,644 | ) |  |  |  | 28.89 |
Forfeited |  |  |  |  |  |  |  |  | (12,853 | ) |  |  |  | 23.52 |
Outstanding and nonvested at December 29, 2018 |  |  |  |  |  |  |  |  | 822,819 |  |  | $ |  | 23.07 |
The total fair value of shares vested was $4.8 million, $9.3 million and $6.6 million in 2018, 2017 and 2016, respectively. Stock-based compensation expense recognized and included in “Selling, general and administrative expenses” in the consolidated statements of operations, and related tax benefits were as follows:
(In thousands) |  |  |  | 2018 |  |  | 2017 |  |  | 2016 |
Restricted stock |  |  |  | $ |  | 7,646 |  |  | $ |  | 9,611 |  |  | $ |  | 7,936 |
Tax benefits |  |  |  |  |  | (2,242 | ) |  |  |  | (3,440 | ) |  |  |  | (2,976 | )
Stock-based compensation expense, net of tax |  |  |  | $ |  | 5,404 |  |  | $ |  | 6,171 |  |  | $ |  | 4,960 |
As of December 29, 2018, total unrecognized compensation cost related to non-vested share-based awards granted under the stock incentive plans was $4.2 million for restricted stock. The remaining compensation costs not yet recognized are expected to be recognized over a weighted average period of 2.4 years for restricted stock. All compensation costs related to stock options have been recognized. The Company recognized tax deductions of $5.6 million, $11.6 million and $8.0 million related to the exercise of stock options and the vesting of restricted stock in 2018, 2017 and 2016, respectively. The Company sponsors a stock bonus plan covering 300,000 shares of SpartanNash common stock. Under the provisions of this plan, certain officers and key associates may elect to receive a portion of their annual bonus in common stock rather than cash and will be granted additional shares of common stock worth 20% of the portion of the bonus they elect to receive in stock. After the shares are issued, the holder is not able to sell or otherwise transfer the shares until the end of the holding period, which is currently 24 months. Compensation expense is recorded based upon the market price of the stock as of the measurement date. During the year, the Company authorized the issuance of an additional 45,000 shares to be granted by the stock bonus plan. A total of 45,000 shares remained unissued under the stock bonus plan at December 29, 2018. The Company also sponsors an associate stock purchase plan covering 200,000 shares of SpartanNash common stock. The plan provides that associates of the Company may purchase shares at 95% of the fair market value. As of December 29, 2018, a total of 100,412 shares had been issued under the plan.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration